Please login to the form below

Not currently logged in
Email:
Password:

MET inhibitor

This page shows the latest MET inhibitor news and features for those working in and with pharma, biotech and healthcare.

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China

AstraZeneca (AZ) and HUTCHMED have received the first regulatory approval for their oral MET inhibitor Orpathys with an authorisation from China’s National Medical Product Administration (NMPA) for a rare type ... In March  2020, Merck KGaA’s oral

Latest news

More from news
Approximately 3 fully matching, plus 32 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...